https://quantisnow.com/insight/1046468?s=s Soon the price will pick up all the positive developments: Biogen Royalties, Sale of Manufacturing Operations to Catalent Debt payment, https://ih.advfn.com/stock-market/NASDAQ/acorda-therapeutics-ACOR/stock-news/85375189/current-report-filing-8-k new target price $ 10